Similar articles

• Resistance in uropathogens among HIV-positive Kenyan and Cambodian children in comparison to an HIV-negative population in south Sudan.

  Augustin A, Shahum A, Taziar M, Benca J, Koleno B, Bukovino P, Holecko K, Secko S, Kral J, Duris M, Ocenas M, Horvath D, Sladecko V, Kniezo Z, Bartkovjak M, Havlik Z, Kalavsky E, Liska A, Krcmery V. Augustin A, et al. Chemotherapy. 2007;53(5):383-4. doi: 10.1159/000107727. Epub 2007 Sep 3. Chemotherapy. 2007. PMID: 17785975 No abstract available.
• Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, Kenya.

  Mwachari CW, Shepherd BE, Cleopa O, Odhiambo JA, Cohen CR. Mwachari CW, et al. Int J STD AIDS. 2004 Feb;15(2):120-6. doi: 10.1258/095646204322764325. Int J STD AIDS. 2004. PMID: 15006075
• [Treatment with aztreonam of gram negative infections in patients seropositive for HIV].

  Catania S, Mascellino MT, Trinchieri V, Musso R, Lorenzi A, Cirelli A. Catania S, et al. Riv Eur Sci Med Farmacol. 1988 Aug;10(4):317-21. Riv Eur Sci Med Farmacol. 1988. PMID: 3274906 Italian. No abstract available.
• [Skin manifestations in HIV infection].

  Büchner SA. Büchner SA. Schweiz Rundsch Med Prax. 1990 May 2;79(18):551-6. Schweiz Rundsch Med Prax. 1990. PMID: 2140197 Review. German.
• [Opportunistic infections in HIV-infected patients].

  Vonwiller HM. Vonwiller HM. Schweiz Rundsch Med Prax. 1990 May 2;79(18):557-61. Schweiz Rundsch Med Prax. 1990. PMID: 2187221 Review. German.